HC Wainwright Reaffirms “Buy” Rating for Vivani Medical (NASDAQ:VANI)
Vivani Medical (NASDAQ:VANI – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a report released on Monday,Benzinga reports. They currently have a $4.00 price target on the stock. HC Wainwright’s target price would suggest a potential upside of 247.83% from the company’s current price. Vivani Medical […]
Vivani Medical (NASDAQ:VANI – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a report released on Monday,Benzinga reports. They currently have a $4.00 price target on the stock. HC Wainwright’s target price would suggest a potential upside of 247.83% from the company’s current price. Vivani Medical […]
